Evidence map›Paper›PMID 26356132›Full record

ArticleCancer cytopathology2016

Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.

Paolo Giorgi Rossi, Guglielmo Ronco, Joakim Dillner, K Miriam Elfström, Peter J F Snijders, Marc Arbyn, Johannes Berkhof, Francesca Carozzi, Annarosa Del Mistro, Silvia De Sanjosè and 7 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Cancer cytopathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Molecular Features of HPV-Independent Cervical Cancers.Pathogens (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Cervical Screening Performance.American journal of clinical pathology · 2021
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Paolo Giorgi RossiInterinstitutional Epidemiology Unit, Azienda Unita Sanitaria Locale di Reggio Emilia, Reggio Emilia, Italy, Arcispedale S. Maria Nuova, National Institute for Research and Treatment, Reggio Emilia, Italy.
Guglielmo RoncoCenter for Cancer Epidemiology and Prevention, AO City of Health and Science, Turin, Italy.
Joakim DillnerKarolinska Institute, Stockholm, Sweden.
K Miriam ElfströmKarolinska Institute, Stockholm, Sweden.
Peter J F SnijdersDepartment of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
Marc ArbynBelgian Cancer Center, Scientific Institute of Public Health, Brussels, Belgium.
Johannes BerkhofDepartment of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
Francesca CarozziS. C. Laboratory for the Prevention of Cancer, Institute for the Study and Prevention of Cancer, Florence, Italy.
Annarosa Del MistroVeneto Institute of Oncology, National Institute for Research and Treatment, Padua, Italy.
Silvia De SanjosèCancer Epidemiology Research Program, Catalan Institute of Oncology, Barcelona, Spain.
Xavier BoschCancer Epidemiology Research Program, Catalan Institute of Oncology, Barcelona, Spain.
Karl Ulrich PetryDepartment of Obstetrics and Gynecology, Wolfsburg Hospital, Wolfsburg, Germany.
Mario PoljakInstitute of Microbiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Carlo NaldoniRegione Emilia-Romagna, Bologna, Italy.
Chris J L M MeijerDepartment of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
Comparing Health Services Interventions for the Prevention of HPV-Related Cancer Consortium
New Technologies for Cervical Cancer Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Early Detection of CancerFemaleHumansPapillomaviridaePapillomavirus InfectionsUterine Cervical Neoplasms

Identifiers

PMID26356132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.